Eptinezumab Treatment was Associated with Longer Interictal Periods and Larger Improvements in Quality of Life Than Placebo in Participants with Migraine for Whom 2-4 Prior Preventive Treatments had Failed: A Post Hoc Analysis of the DELIVER Trial

Comparative Efficacy, Safety, and Tolerability of Atogepant and Erenumab: Indirect Treatment Comparison of the TEMPLE and HER-MES Head-to-head Trials

Real-world Effectiveness of Eptinezumab in Chronic Migraine: A 4-year Retrospective Longitudinal Cohort Study

Treatment with Fremanezumab Attenuates the Association Between Weather and Headache in Participants with Episodic Migraine: A Post Hoc Analysis of the HALO-EM and HALO-LTS Studies